Veradermics, Inc. (MANE)

114.91 -0.81 (-0.70%) USD  |  NYSE  |  Sep 25, 11:36
More

Veradermics Shareholders Equity (Quarterly) : 814.21M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for MANE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 814.21M
March 31, 2026 391.87M
December 31, 2025 145.31M
Date Value
June 30, 2025
March 31, 2025
December 31, 2024 54.66M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 33.88B
EyePoint, Inc. 166.41M
Elanco Animal Health, Inc. 6.588B
Amylyx Pharmaceuticals, Inc. 239.17M
ANI Pharmaceuticals, Inc. 597.21M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 826.33M
Total Liabilities (Quarterly) 12.12M
Debt to Equity Ratio 0.0005
Current Ratio 70.53
Net Debt Paydown Yield 0.00%